Literature DB >> 16669834

Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.

M Sezikli1, S Guliter, T Z Apan, A Aksoy, H Keles, Z N Ozkurt.   

Abstract

Infection with Helicobacter pylori (H. pylori) strains secreting cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA) proteins is associated with more severe gastroduodenal pathologies. However, this association varies among geographical regions and ethnic groups. We investigated the frequencies of antibodies to CagA and VacA proteins in 131 H. pylori-infected dyspeptic patients [40 duodenal ulcer (DU), 19 gastric ulcer (GU), 28 gastric cancer (GC), and 44 non-ulcer dyspepsia (NUD)] across 30 H. pylori-infected and endoscopically normal asymptomatic subjects (AS). Anti-CagA and anti-VacA antibodies were detected by Western blotting. The positivity rates of anti-CagA and anti-VacA antibodies were higher in patients with DU (92.5 and 75%), GU (89.5 and 84.2%) and GC (96.4 and 85.7%) than patients with NUD (70.5 and 50%) and AS (50 and 23.3%) (p < 0.05). CagA+ VacA+ phenotype was more frequent in patients with DU, GU and GC than patients with NUD and AS (75, 84.2, 85.7 vs. 47.7 and 20%, respectively) (p < 0.01). Our results showed that there is a significantly positive association between the presence of anti-CagA and anti-VacA antibodies and DU, GU and GC in our region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16669834     DOI: 10.1111/j.1742-1241.2005.00778.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

2.  Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis.

Authors:  Georgios Efthymiou; Christos Liaskos; Theodora Simopoulou; Emmanouela Marou; Eleni Patrikiou; Thomas Scheper; Wolfgang Meyer; Dimitrios Daoussis; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  Immunol Res       Date:  2020-02       Impact factor: 2.829

3.  Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.

Authors:  Meira Epplein; Michael Pawlita; Angelika Michel; Richard M Peek; Qiuyin Cai; William J Blot
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

4.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

5.  The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients.

Authors:  Hasan Umit; Ahmet Tezel; Sebnem Bukavaz; Gulbin Unsal; Muserref Otkun; Ali Riza Soylu; Dilek Tucer; Metin Otkun; Selcuk Bilgi
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

6.  Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis.

Authors:  Georgios Efthymiou; Efthymios Dardiotis; Christos Liaskos; Emmanouela Marou; Vana Tsimourtou; Eirini I Rigopoulou; Thomas Scheper; Alexandros Daponte; Wolfgang Meyer; Lazaros I Sakkas; Georgios Hadjigeorgiou; Dimitrios P Bogdanos
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 7.  Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Toxins (Basel)       Date:  2019-11-19       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.